BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17537736)

  • 1. Status and plans for implementation of NRC regulatory authority for certain naturally occurring and accelerator-produced radioactive material.
    Mauer A
    J Nucl Med Technol; 2007 Jun; 35(2):112-3. PubMed ID: 17537736
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined guide to NRC compliance now available.
    J Nucl Med; 2004 Jun; 45(6):28N. PubMed ID: 15181116
    [No Abstract]   [Full Text] [Related]  

  • 3. Nuclear medicine affected by Energy Policy Act of 2005.
    J Nucl Med; 2005 Oct; 46(10):12N, 14N. PubMed ID: 16312055
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
    Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notification of the next phase of waiver terminations in the implementation of NRC regulatory authority for certain naturally occurring and accelerator-produced radioactive material.
    White D
    J Nucl Med Technol; 2009 Mar; 37(1):60-1. PubMed ID: 19223427
    [No Abstract]   [Full Text] [Related]  

  • 6. The U.S. NRC and the ADR process learning experiences.
    Pérez-Monté JE
    Health Phys; 2011 Nov; 101 Suppl 3():S160-3. PubMed ID: 21968823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Departures from manufacturer's instructions; elimination of recordkeeping requirements--NRC. Final rule.
    Fed Regist; 1992 Oct; 57(192):45566-8. PubMed ID: 10121203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification.
    Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical administration of radiation and radioactive materials--NRC. Final rule.
    Fed Regist; 1995 Sep; 60(182):48623-6. PubMed ID: 10151185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Society sues NRC over radiopharmacy rule.
    Kotz D
    J Nucl Med; 1995 Mar; 36(3):14N-15N, 20N-21N. PubMed ID: 7884491
    [No Abstract]   [Full Text] [Related]  

  • 11. In addition to the current byproduct materials, it is important that the nuclear regulatory commission take over regulation of naturally occurring and accelerator-produced radioactive materials. Against the proposition.
    Wilson JF
    Med Phys; 2006 Feb; 33(2):256-8. PubMed ID: 16532929
    [No Abstract]   [Full Text] [Related]  

  • 12. Procedure guideline for the use of radiopharmaceuticals 4.0.
    Callahan RJ; Chilton HM; Ponto JA; Swanson DP; Royal HD; Bruce AD
    J Nucl Med Technol; 2007 Dec; 35(4):272-5. PubMed ID: 18006598
    [No Abstract]   [Full Text] [Related]  

  • 13. Congressional subcommittee scrutinizes looming U.S. radioisotope supply crisis.
    Rojas-Burke J
    J Nucl Med; 1992 Oct; 33(10):16N, 21N-22N, 34N. PubMed ID: 1403135
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical use of byproduct material; draft policy statement--NRC. draft policy statement.
    Fed Regist; 1998 Aug; 63(156):43580-6. PubMed ID: 10182574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive quality assurance in medical use and a standard of care--NRC. Advance notice of proposed rulemaking: withdrawal.
    Fed Regist; 1998 Dec; 63(231):66496. PubMed ID: 10338878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for the release of individuals administered radioactive materials--NRC. Final rule.
    Fed Regist; 1997 Jan; 62(19):4120-33. PubMed ID: 10164806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early closing of accelerator could impede nuclear medicine research.
    Rojas-Burke J
    J Nucl Med; 1993 Jun; 34(6):51N, 54N-55N. PubMed ID: 8509851
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical use of byproduct material: issues and request for public input--NRC. Request for public input on rule development.
    Fed Regist; 1997 Aug; 62(151):42219-20. PubMed ID: 10169835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current NRC definitions of therapy misadministration are vague, do not reflect the norms of clinical practice, and should be rewritten. For the proposition.
    Amols H
    Med Phys; 2004 Apr; 31(4):691-3. PubMed ID: 15124984
    [No Abstract]   [Full Text] [Related]  

  • 20. New NRC rule spurred by radiation incidents. Motivated by two recent acts of suspected radiation sabotage, the Nuclear Regulatory Commission wants any future events to be reported within 24 hours. Will the new rule prevent international misadministrations or just cause unnecessary paperwork?
    Kotz D
    J Nucl Med; 1996 Jun; 37(6):15N-9N. PubMed ID: 8683302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.